← back to database
A multi-strategy investment firm focused on breakthrough biomedical technology companies worldwide.
Primary stage
Lead / follow
Hardware / software
Investment focus
Investors
George C. Petrocheilos, R. Jacob Vogelstein, Tom V. Brooks, John Henry Iucker, Edward J. Mathias, Scott O’Sullivan, Isaac Ro